Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Can J Physiol Pharmacol ; 88(1): 28-37, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20130736

ABSTRACT

We studied whether substitution of soy protein for casein can improve insulin sensitivity, lower blood pressure (BP), and inhibit protein kinase C betaII (PKCbetaII) activation in kidney in an acquired model of metabolic syndrome. Adult male rats were fed 4 different diets: (i) starch (60%) and casein (20%) (CCD), (ii) fructose (60%) and casein (20%) (FCD), (iii) fructose (60%) and soy protein (20%) (FSD), and (iv) starch (60%) and soy protein (20%) (CSD). Renal function parameters, BP, pressor mechanisms, PKCbetaII expression, oxidative stress, and renal histology were evaluated after 60 days. FCD rats displayed insulin resistance and significant changes in body weight, kidney weight, urine volume, plasma and urine electrolytes accompanied by significant changes in renal function parameters compared with CCD rats. Elevated BP, plasma angiotensin-converting enzyme (ACE) activity, renal oxidative stress, and reduced nitrite (NO) and kallikrein activity were observed. Western blot analysis revealed enhanced renal expression of membrane-associated PKCbetaII in the FCD group. Histology showed fatty infiltration and thickening of glomeruli while urinary protein profile revealed a 5-fold increase in albumin. Substitution of soy protein for casein improved insulin sensitivity, lowered BP and PKCbetaII activation and restored renal function. Antioxidant action, inhibitory effect on ACE and PKCbetaII activation, and increased availability of kinins and NO could be contributing mechanisms for the benefits of dietary soy protein.


Subject(s)
Antihypertensive Agents/therapeutic use , Disease Models, Animal , Hypertension/enzymology , Kidney Diseases/diet therapy , Metabolic Syndrome/diet therapy , Metabolic Syndrome/enzymology , Protein Kinase C/antagonists & inhibitors , Soybean Proteins/therapeutic use , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Blood Pressure/physiology , Dietary Proteins/pharmacology , Dietary Proteins/therapeutic use , Hypertension/diet therapy , Hypertension/physiopathology , Kidney Diseases/enzymology , Kidney Diseases/prevention & control , Male , Metabolic Syndrome/physiopathology , Protein Kinase C/physiology , Protein Kinase C beta , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , Rats , Rats, Wistar , Soybean Proteins/pharmacology
2.
Asia Pac J Clin Nutr ; 14(4): 420-7, 2005.
Article in English | MEDLINE | ID: mdl-16326650

ABSTRACT

High fructose feeding in rats induces insulin resistance, hyperinsulinemia, hyperglycemia and dyslipidemia. The present study was undertaken to determine the hypolipidemic effect of food seasoning spices mixture on fructose-fed insulin resistant rats. Male Wistar rats received a daily diet containing either 60% fructose or 60% starch. They were administered with the spices mixture at three different doses (10 mg, 30 mg or 50 mg/day/rat) orally 15 days later. At the end of 45 days of the experimental period fructose-fed rats displayed elevated plasma glucose and insulin levels and dyslipidemia which included elevated levels of cholesterol, triglycerides, free fatty acids, reduced high density lipoprotein cholesterol and increased very low density lipoprotein cholesterol. Alterations in tissue lipid levels were also observed. Simultaneous treatment with spices mixture along with fructose diet resulted in the normalization of plasma glucose and insulin levels and restoration of lipid levels in plasma and tissues. The insulin potentiating action of the active principles in these spices may contribute to the hypolipidemic effect of spices mixture in high fructose-fed rats.


Subject(s)
Blood Glucose/drug effects , Hyperlipidemias/drug therapy , Hypolipidemic Agents/pharmacology , Lipid Metabolism/drug effects , Plant Extracts/pharmacology , Spices , Animals , Blood Glucose/metabolism , Cholesterol/blood , Dose-Response Relationship, Drug , Fructose/pharmacology , Insulin/blood , Insulin Resistance , Lipids/blood , Lipoproteins/blood , Male , Random Allocation , Rats , Rats, Wistar , Triglycerides/blood
3.
J Diabetes Complications ; 19(5): 305-11, 2005.
Article in English | MEDLINE | ID: mdl-16112507

ABSTRACT

OBJECTIVE: The aim of the study is to investigate the effect of taurine administration on the content and characteristics of skin collagen in high-fructose-fed rats. RESEARCH DESIGN AND METHODS: Adult male Wistar rats were divided into four groups of six each: a control group (CON) and a taurine-supplemented control group (CON+TAU), a high fructose diet-fed group (FRU), and a taurine supplemented fructose diet-fed group (FRU+TAU). After 30 days, collagen was isolated from the skin, and its physicochemical properties were studied. RESULTS: Fructose administration caused an accumulation of collagen and extensive cross-linking. This was evidenced by increases in glycation, fluorescence, and peroxidation in collagen samples. The physicochemical properties of collagen, like shrinkage temperature, aldehyde content, solubility pattern, and susceptibility to denaturing agents, were altered in the fructose-fed rats. The sodium dodecyl sulphate-polyacrylamide gel electrophoretic (SDS-PAGE) pattern of collagen from fructose-fed rats showed and elevated beta component of Type I collagen. Simultaneous administration of taurine alleviated these changes. CONCLUSION: The positive influence of taurine on both collagen content and its properties suggests a potential mechanism for the ability of taurine to delay diabetic complications.


Subject(s)
Collagen/metabolism , Fructose/administration & dosage , Skin/drug effects , Taurine/pharmacology , Animals , Collagen/chemistry , Diet , Glycation End Products, Advanced , Male , Rats , Rats, Wistar , Skin/metabolism , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...